News | Breast Density | September 12, 2018

California’s Dense Breast Inform Law Extended Through 2025

State’s 2013 Density Inform Law Sunset on January 1, 2019 Rescinded

breast cancer

Calif. Gov. Jerry Brown’s signature this week on Dense Breast Tissue Awareness bill (SB-1034) means the requirement to notify California women about breast density will continue uninterrupted through January 1, 2025.

To date, four state dense breast inform laws requiring notification have been enacted with sunset clauses setting an expiration date: North Dakota, California, Washington and Florida.  North Dakota’s law, which went into effect in April 2015, expired on July 31, 2017. Washington’s law sunsets on January 1, 2025 and Florida’s on June 30, 2023.

In her presentation to the California Assembly Health Committee, the bill’s sponsor Senator Holly J. Mitchell stated, “Patients are their own best advocates; they cannot be effective advocates if they are not informed.”

According to patient advocate Amy Colton, who spearheaded efforts for both the original and current legislation, “This is potentially life-saving information for the women of California. While our hopes were for a complete repeal of the sunset clause, we are grateful California women will continue to receive information about their breast density and its implications for cancer detection and risk. The notification provides a foundation for the continued, critical conversation between patients and physicians to increase early detection.”

Senator Mitchell’s office requested scientific background and input from DenseBreast-info.org (DB-I) to support the legislative effort. “Breast cancer screening either is important or it’s not,” added JoAnn Pushkin, DB-I executive director, “And if it is, being an informed patient is particularly important for those women with dense breasts who are both at greater risk of developing breast cancer and of having that cancer missed by mammography.”

While 35 states now have enacted legislation, they vary in depth and breadth of notification, and not all density inform laws actually require that women be provided information about their own breast density.  The call is growing for a single national reporting standard to address this disparity. On the federal regulatory level, the Food and Drug Administration anticipates publishing proposed amendments to the Mammography Quality Standards Act regulations for notice or comment.  On the federal legislative front, the Breast Density and Mammography Reporting Act of 2017 has been introduced in both the Senate (S 2006) and House (HR 4122).

For further explanation about federal efforts and for state-by-state legislative analysis, visit the Legislative Information tab at educational website DenseBreast-info.org.

Also see:

Confused About Mammography Screening Guidelines?

California Women In Favor of Extending State's Breast Density Inform Law

VIDEO: Developments in Breast Density Legislation and Screening Guidelines

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...